Tachyon Ventures
Overview
Tachyon Ventures is a venture capital firm that focuses on early-stage investments in companies in the medicine, biotech, and bioengineering sectors. The firm seeks to invest in companies with protected IP.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Scipher Medicine | Feb 2020 | Series B | Co-investor |
| Stylus Medicine | May 2025 | Series A Extension | Co-investor |
| EnClear Therapies | Sep 2024 | VC Round | Co-investor |
| Palm Therapeutics, Inc. | Jan 2024 | SAFE | Lead |
| Axonis Therapeutics | Oct 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tachyon Ventures based?
Tachyon Ventures is headquartered in Los Angeles, California, United States.
When was Tachyon Ventures founded?
Tachyon Ventures was founded in 2017.
How many portfolio companies does Tachyon Ventures have?
Tachyon Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Tachyon Ventures's portfolio?
Portfolio companies visible on Caplight include Scipher Medicine, Stylus Medicine, EnClear Therapies, Palm Therapeutics, Inc., Axonis Therapeutics.
What was Tachyon Ventures's most recent investment shown here?
Tachyon Ventures's most recent investment in this portfolio sample was in Stylus Medicine in 2025.
What sectors does Tachyon Ventures focus on?
Tachyon Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Crypto & Web3, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Tachyon Ventures focus on?
Tachyon Ventures typically invests at the Early stage.
What is Tachyon Ventures's AUM?
Tachyon Ventures's assets under management are estimated between $0.0 and $50.0M.